Conferences and Speeches

A Practical Guide for Chemical/Biotech US Patent Practice

Wednesday, October 5, 2016
12:00 PM - 01:30 PM Japan Standard Time

The discussion was held in Tokyo, Japan regarding chemical and biotech patent practice in the United States.

Introduction | 12:00–12:05 pm

Patentable Subject Matter
| 12:05–12:40 pm
Janice H. Lee and Kosuke Kimoto (of SOEI)

米国最高裁判所は、最近、米国連邦巡回裁判所のAriosa Diagnostics、Inc. v. Sequenom、Inc.における特許適格性を検討する申立書を拒否する決断をくだしました。しかし、その後、米国連邦巡回裁判所は、Rapid Litigation Management v.CellzDirectにおいて、地方裁判所における特許適格性の判決を覆したため、この判決をうけて、我々は、何が特許不適格であるのか、というよりむしろ、何が特許適格性の対象となり得るのかという判断を行うことができるようになりました。従って、セミナーにおいては、近年の判例を反映した最新の審査基準、並びに米国特許庁が公開しているライフサイエンス分野に関する実施例とメモランダムについて解説し、これらをどのように実務で使用できるのかについて解説します。

The US Supreme Court recently denied a petition to review the US Court of Appeals for the Federal Circuit’s determination of patent-ineligibility in Ariosa Diagnostics, Inc. v. Sequenom, Inc. In the last few months, however, the Federal Circuit overturned some district court decisions that certain patents were directed to patent-ineligible subject matter and shed some light on what would be patent-eligible rather than ineligible. Please join us for a review of the recent guidelines from the courts and to discuss practical use of currently available US Patent and Trademark Office examination guidelines for obtaining patents.

Comparing US and JP Arguments for Written Description and Enablement
| 12:50–1:30 pm
Janice H. Lee and Yoshinori Shimizu (of SOEI)


The United States and Japan have different laws and rules for written description and enablement requirements, and an effective response to an examiner’s rejection must be in accordance with each country’s practice. In chemical and biotech art, however, a US examiner’s written description and enablement rejections are often lengthy and complex. We will discuss how to better respond to written description and enablement rejections under 35 U.S.C. § 112.

This seminar will be followed by a seminar at 2:00 pm: A Practical Guide for US Patent Practice.

There is no cost to attend.


For registration or for more information, please contact Yoshinori Shimizu at or Janice Lee at